MedTrace Logo

Furosemide for Accelerated Recovery of Blood Pressure Postpartum

NCT03556761 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 384

Last updated 2020-09-10

Study results available
· View outcomes & findings →

Summary

A randomized, double-blind, placebo-controlled single center investigation of furosemide's effect on postpartum blood pressure control in pregnancies affected by hypertensive disorders of pregnancy

Conditions

  • Hypertension, Pregnancy-Induced

Interventions

DRUG

Oral furosemide

Furosemide (Lasix), 20 milligram, PO, PO, daily

DRUG

Placebo Oral Tablet

Placebo, PO, daily

Sponsors & Collaborators

Principal Investigators

  • Lisa Levine, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2019-12-04
Completion
2020-02-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556761 on ClinicalTrials.gov